Hunter-gatherers in parts of ancient Asia prepared their dead for burial with smoke-drying up to 14,000 years ago, resulting ...
With the U.S. presidential election just two weeks away, Deutsche Bank Research found the S&P 500 has seen a long stretch of annualized double-digit returns under different White House administrations ...
On Wednesday morning, Pablo Torre dropped a bombshell that was felt all across the NBA. In an 80-minute episode of "Pablo Torre Finds Out," Torre revealed a secret $28 million endorsement deal that ...
Memorial Healthcare System’s doctors, specialists, and hospitals are no longer in the network for Florida Blue policyholders, the state’s largest health insurer. As of Sept. 1, the contract between ...
Some investors are not happy that Intel agreed to sell the US a 10 percent stake in the company after Donald Trump attacked Intel CEO Lip-Bu Tan with a demand to resign. After Intel accepted the deal ...
European Union trade commissioner Maros Sefcovic on Thursday presented a joint EU-US statement outlining a framework trade deal under which some 70% of EU exports face a 15% tariff. "This is a serious ...
Tariff news highlights: The additional 25% tariffs on Indian imports, imposed by US President Donald Trump, came into effect today, taking the total tariff on India to reach 50%. Why were additional ...
Thinking about leveling up your software development game in 2025? It’s a smart move. The tech world moves fast, and getting ...
Meghan Markle's partnership with Netflix to sell her As Ever brand products appears to be faltering, as her jam and pancake mix are not listed on the website. Doubts are growing about the brand's ...
Chelsea have agreed a deal with Manchester United for the signing of Alejandro Garnacho. The deal consists of a £40million fixed fee and a 10 per cent sell-on clause is also included as part of the ...
Kawhi Leonard had plenty of reasons to sign an extension with the Los Angeles Clippers, but one of the biggest ones may have been a $28M no-show job. Exclusive: Kawhi Leonard signed a $28M endorsement ...
Novartis is taking another shot at alpha-synuclein as a target for treating Parkinson’s disease via a $200 million upfront licensing deal with Arrowhead Pharmaceuticals. The Swiss pharma plans to use ...